Literature DB >> 14409280

Treatment of staphylococcal septicemia with vancomycin: report of thirty-three cases.

W M KIRBY, D M PERRY, A W BAUER.   

Abstract

Entities:  

Keywords:  ANTIBIOTICS/therapy; SEPTICEMIA/therapy; STAPHYLOCOCCAL INFECTIONS/therapy

Mesh：

Substances：

Year:  1960        PMID： 14409280     DOI： 10.1056/NEJM196001142620201

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  10 in total

1.  Hypotension and oliguria in staphylococcal pneumonia.

Authors:  G KELLAWAY; H LE GRICE
Journal:  Br Med J       Date:  1962-02-17

Review 2.  Vancomycin- and erythromycin-induced hearing loss in humans.

Authors:  R E Brummett; K E Fox
Journal:  Antimicrob Agents Chemother       Date:  1989-06       Impact factor: 5.191

3.  Mycobacterium avium-M. intracellulare and Acquired Immunodeficiency Syndrome.

Authors:  E Wolinsky; C R Horsburgh; D L Cohn; R B Roberts; H Masur; R Miller; A Y Tsang; M D Iseman
Journal:  Antimicrob Agents Chemother       Date:  1987-06       Impact factor: 5.191

4.  Infectious disease emergencies. Part II: patients presenting with cardiac decompensation or circulatory insufficiency (shock).

Authors: 
Journal:  West J Med       Date:  1976-08

5.  Current antibiotic usage II: Aminoglycosides, tetracyclines, erythromycin, vancomycin and sulphonamides.

Authors:  S M Merchant; N P Vithlani
Journal:  Indian J Pediatr       Date:  1986 Mar-Apr       Impact factor: 1.967

6.  Staphylococcus aureus bacteremia: A critical review of its treatment and association with infective endocarditis.

Authors:  T W Austin; J F Wallace
Journal:  Infection       Date:  1973       Impact factor: 3.553

7.  Evaluation of an automated fluorescence polarization immunoassay for vancomycin.

Authors:  B H Filburn; V H Shull; Y M Tempera; J D Dick
Journal:  Antimicrob Agents Chemother       Date:  1983-08       Impact factor: 5.191

Review 8.  Pharmacokinetic optimisation of vancomycin therapy.

Authors:  W G Leader; M H Chandler; M Castiglia
Journal:  Clin Pharmacokinet       Date:  1995-04       Impact factor: 6.447

Review 9.  Clinical pharmacokinetics of vancomycin.

Authors:  G R Matzke; G G Zhanel; D R Guay
Journal:  Clin Pharmacokinet       Date:  1986 Jul-Aug       Impact factor: 6.447

10.  Ascorbic acid, ultraviolet C rays, and glucose but not hyperthermia are elicitors of human β-defensin 1 mRNA in normal keratinocytes.

Authors:  Luis Antonio Cruz Díaz; María Guadalupe Flores Miramontes; Paulina Chávez Hurtado; Kirk Allen; Marisela Gonzalez Ávila; Ernesto Prado Montes de Oca
Journal:  Biomed Res Int       Date:  2015-03-01       Impact factor: 3.411
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.